Dael Govreen-Segal is the co-founder and CEO of G&G Biotechnology and the project leader for the development of the world’s lightest breast implants.
Mr. Govreen-Segal has held senior technical, marketing and management positions in both established, public companies and start-ups. He managed a cancer related non-profit organization and has founded 3 successful healthcare companies.
Mr. Govreen-Segal’s engineering background has driven his passion and dedication to innovate through applied science.
Mr. Govreen-Segal graduated first from Ben Gurion University (B.Sc. in Electronics and Computer Engineering) and subsequently with High Honors from Tel-Aviv University (M.Sc. in Biomedical Engineering).